Fr. 253.20

Metabolism, Pharmacokinetics and Toxicity of Functional Groups - Impact of Chemical Building Blocks on Admet

Anglais · Livre Relié

Expédition généralement dans un délai de 3 à 5 semaines (titre commandé spécialement)

Description

En savoir plus

Informationen zum Autor Professor Dennis Smith has worked in the pharmaceutical industry for 32 years after gaining his Ph.D from the University of Manchester. For 20 years he was at Pfizer Global Research and Development, Sandwich where he was Vice President-Pharmacokinetics, Dynamics and Metabolism. For the past 2 years he has been a Pfizer Academic Research Fellow working on a part-time basis. His research interests and publications span all aspects of Drug Discovery and Development particularly where drug metabolism knowledge can impact on the design of more efficacious and safer drugs. During this 30-year span he has helped in the Discovery and Development of eight marketed NCEs. He has authored over 100 publications including two books. Klappentext This outstanding book provides insight into the metabolism, pharmacokinetics and toxicity (ADMET) of chemicals by dividing the subject into functional groups. Following a description of chemical space and general ADMET in a unique way, by referring to actual chemical structures (functional groups) which even influence the molecules, they are incorporated into, in a specific manner. Many of the groupings are characterise the pharmacology of the drugs and are essential for particular activity; they are also a major influence in changing ADMET characteristics. These changes follow a pattern, thus allowing medicinal chemists to understand likely changes and how these can be overcome. Each chapter describes drugs containing the group, why the group is there and the physiochemical properties of a functional group before detailing the ADMET issues. In addition prodrugs and biosioteres are described where possible which may give alternative ADMET outcomes. The final chapter looks at future needs in terms of chemistry and ADMET understanding. Written by a team of scientists from Pfizer the book will appeal to postgraduate medicinal chemists and those working in industry. Zusammenfassung Written by medicinal chemists and ADMET scientists with a combined experience of over 300 years this aid to discovering drugs provides detailed coverage on absorption! distribution! metabolism! excretion and toxicology issues associated with new drugs. Inhaltsverzeichnis Drug targets and their structural motifs; ADMET for the medicinal chemist; Carboxlic acids and their isosteres; Primary, secondary and tertiary amines and isosteres; Sulphonamide as an essential group; 1, 2 and 3 ring phenyl and heterocyclic cores; Heterocycles and phenyls as essential pharmacophore groups; Peptides and peptidomimetic cores; Peptides and peptidomimetics as functional groups; Transition state functions; Alcohols and carbonyls; Future targets and chemistry needs;...

Détails du produit

Auteurs Dennis A Smith, Dennis A. Smith
Collaboration David Fox (Editeur), Dennis A Smith (Editeur), Dennis A. Smith (Editeur), Dennis Allen Smith (Editeur)
Edition Royal Society Of Chemistry
 
Langues Anglais
Format d'édition Livre Relié
Sortie 09.04.2010
 
EAN 9781849730167
ISBN 978-1-84973-016-7
Pages 544
Thèmes RSC Drug Discovery
Drug Discovery
Drug Discovery
RSC Drug Discovery
Catégorie Sciences naturelles, médecine, informatique, technique > Médecine > Spécialités cliniques

Commentaires des clients

Aucune analyse n'a été rédigée sur cet article pour le moment. Sois le premier à donner ton avis et aide les autres utilisateurs à prendre leur décision d'achat.

Écris un commentaire

Super ou nul ? Donne ton propre avis.

Pour les messages à CeDe.ch, veuillez utiliser le formulaire de contact.

Il faut impérativement remplir les champs de saisie marqués d'une *.

En soumettant ce formulaire, tu acceptes notre déclaration de protection des données.